Delivery Order SPE2DB20D1109-SPE2DB21FP76L
- Not listed
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,364.54 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a firm fixed-price delivery order with an ultimate completion date of August 31, 2023. This award is not associated with a set-aside program, indicating open competition. Amerisourcebergen...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, valued at $1,477.70, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 27, 2021, with a ceiling value of $1,129.45. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 28, 2021. Amerisourcebergen Drug Corp is a...
- This federal contract award, valued at $1,524.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Quillivant XR, a 25 mg/5 ml suspension medication, with a completion date of June 23, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 60 ml bottles. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,024.80 and runs through December 10, 2024. This is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) to the Defense Logistics Agency (DLA). The $2,860.23 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, which runs through November 2026, enables the efficient procurement of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Quillivant XR 25 mg/5 ml suspension, a 60 ml medication. The firm-fixed-price delivery order has a ceiling value of $1,846.75 and an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The $1,154.33 firm fixed-price delivery order has an ultimate completion date of October 24, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The delivery order has a ceiling value of $1,016.24 and a completion date of August 16, 2024. The contract is a firm-fixed-price Delivery Order with no set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to provide the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,286.54, is for the delivery of Quillivant XR 25 mg/5 ml suspension 120 ml, a specialty medication. The award was made as a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB21FP76LDelivery Order
This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on August 11, 2021, with a ceiling value of $2,910.20. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, Amerisourcebergen Drug Corp maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/11/21 |